United Therapeutics Corporation operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares United Therapeutics with three other
companies in this sector in the United States:
Amneal Pharmaceuticals Inc
sales of $1.66 billion
of which 87%
Horizon Therapeutics PLC
of which 21%
was K R Y S T E X X A), and
Biomarin Pharmaceutical Inc
of which 32%
During the year ended December of 2018, sales at
United Therapeutics were $1.63 billion.
decrease of 5.7%
versus 2017, when the company's sales were $1.73 billion.